IPP Bureau
Eli Lilly appoints Dr. Vivek Jha as Senior Director – Commercial Strategy, AI & Transformation
By IPP Bureau - September 03, 2025
He will be leading the design and execution of transformative strategies that harness the power of AI and automation, drive process optimization, and ignite digital innovation
Health Minister Nadda to inaugurate India MedTech Expo 2025
By IPP Bureau - September 03, 2025
The three-day expo will feature an expansive exhibition showcasing MSMEs, startups, research institutions, future innovation pavilions, state showcases, and government initiatives
iPHEX 2025: Global regulatory conclaves to highlight India’s role in shaping global health
By IPP Bureau - September 03, 2025
This year’s edition will witness participation of over 700 Indian exporters showcasing their products and services; 500+ overseas delegates representing more than 120 countries; 20,000 domestic visitors; and 8,000+ B2B meetings
Merck appoints David Weinreich as new Global Head of R&D and CMO for Healthcare Business
By IPP Bureau - September 03, 2025
He has successfully led the development of 15 approved drugs worldwide across various therapeutic areas over his more than 20-year career
FDA grants accelerated approval to Zongertinib for HER2-mutated non-squamous NSCLC
By IPP Bureau - September 03, 2025
New targeted therapy offers hope for patients with unresectable or metastatic NSCLC harboring HER2 tyrosine kinase domain activating mutations
Novartis Leqvio demonstrates strong LDL-C goal achievement with reduced muscle pain
By IPP Bureau - September 03, 2025
The trial is the largest to date evaluating Leqvio and the first to focus on patient-centered outcomes
FDA approves Lecanemab autoinjector, marking first at-home treatment for Alzheimer disease
By IPP Bureau - September 02, 2025
The new subcutaneous autoinjector for lecanemab offers a self-administered, at-home treatment option for early-stage Alzheimer's disease
FDA approves Sanofi’s BTK inhibitor for immune thrombocytopenia
By IPP Bureau - September 02, 2025
ITP is a disease of complex immune dysregulation leading to low platelet counts, bleeding, and reduced quality of life
Fortis takes over 200-bed Greater Noida hospital on long term lease
By IPP Bureau - September 02, 2025
Fortis will assume complete operational and financial control, allowing it to consolidate the hospital's performance within its network
Medanta launches 550-bed super specialty hospital in Noida
By IPP Bureau - September 02, 2025
The hospital opens with 300 operational beds, including 100+ ICU beds and 5 advanced operating theatres
Zydus launches VaxiFlu vaccine for flu protection
By IPP Bureau - September 02, 2025
First Indian company to follow global recommendations in accordance with the World Health Organisation (WHO)
Glenmark Pharmaceuticals USA to launch Eribulin Mesylate injection
By IPP Bureau - September 02, 2025
Glenmark’s Eribulin Mesylate Injection, 1 mg/2 mL (0.5 mg/mL) Single-Dose Vials is bioequivalent and therapeutically equivalent to the reference listed drug, Halaven Injection, 1 mg/2 mL (0.5 mg/mL),of Eisai
Revvity establishes In Vivo Imaging Center of Excellence in North Carolina
By IPP Bureau - September 02, 2025
Facility designed to advance the next generation of imaging systems
India preparing to become hub for medical technology: Pharmaceuticals Secretary
By IPP Bureau - September 01, 2025
Government policies and competitive industry driving India’s MedTech sector for sustained double-digit growth
